236 related articles for article (PubMed ID: 29016747)
1. Five year trends (2008-2012) in cardiac implantable electrical device utilization in five European nations: a case study in cross-country comparisons using administrative databases.
Banks H; Torbica A; Valzania C; Varabyova Y; Prevolnik Rupel V; Taylor RS; Hunger T; Walker S; Boriani G; Fattore G;
Europace; 2018 Apr; 20(4):643-653. PubMed ID: 29016747
[TBL] [Abstract][Full Text] [Related]
2. Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2016 Report from the European Heart Rhythm Association.
Raatikainen MJ; Arnar DO; Merkely B; Camm AJ; Hindricks G
Europace; 2016 Aug; 18 Suppl 3():iii1-iii79. PubMed ID: 27496955
[TBL] [Abstract][Full Text] [Related]
3. Cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy: single center implant data extracted from the Swedish pacemaker and ICD registry.
Valzania C; Gadler F; Boriani G; Rapezzi C; Eriksson MJ
Scand Cardiovasc J; 2020 Aug; 54(4):239-247. PubMed ID: 32054352
[No Abstract] [Full Text] [Related]
4. Facility-Level Variation and Clinical Outcomes in Use of Cardiac Resynchronization Therapy With and Without an Implantable Cardioverter-Defibrillator.
Kramer DB; Normand ST; Volya R; Hatfield LA
Circ Cardiovasc Qual Outcomes; 2018 Dec; 11(12):e004763. PubMed ID: 30562069
[TBL] [Abstract][Full Text] [Related]
5. A Decade of Information on the Use of Cardiac Implantable Electronic Devices and Interventional Electrophysiological Procedures in the European Society of Cardiology Countries: 2017 Report from the European Heart Rhythm Association.
Raatikainen MJP; Arnar DO; Merkely B; Nielsen JC; Hindricks G; Heidbuchel H; Camm J
Europace; 2017 Aug; 19(suppl_2):ii1-ii90. PubMed ID: 28903470
[TBL] [Abstract][Full Text] [Related]
6. Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI).
Lenarczyk R; Boveda S; Haugaa KH; Potpara TS; Syska P; Jedrzejczyk-Patej E; Chauvin M; Sadoul N; Dagres N
Europace; 2018 Jul; 20(7):1218-1224. PubMed ID: 29762683
[TBL] [Abstract][Full Text] [Related]
7. Implantation of subcutaneous implantable cardioverter defibrillators in Europe: results of the European Heart Rhythm Association survey.
Boveda S; Lenarczyk R; Haugaa K; Fumagalli S; Madrid AH; Defaye P; Broadhurst P; Dagres N
Europace; 2016 Sep; 18(9):1434-9. PubMed ID: 27582309
[TBL] [Abstract][Full Text] [Related]
8. Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort.
Varma N; Mittal S; Prillinger JB; Snell J; Dalal N; Piccini JP
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28490521
[TBL] [Abstract][Full Text] [Related]
9. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
Gadler F; Valzania C; Linde C
Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
[TBL] [Abstract][Full Text] [Related]
10. Gender, Racial, and Health Insurance Differences in the Trend of Implantable Cardioverter-Defibrillator (ICD) Utilization: A United States Experience Over the Last Decade.
Patel NJ; Edla S; Deshmukh A; Nalluri N; Patel N; Agnihotri K; Patel A; Savani C; Patel N; Bhimani R; Thakkar B; Arora S; Asti D; Badheka AO; Parikh V; Mitrani RD; Noseworthy P; Paydak H; Viles-Gonzalez J; Friedman PA; Kowalski M
Clin Cardiol; 2016 Feb; 39(2):63-71. PubMed ID: 26799597
[TBL] [Abstract][Full Text] [Related]
11. Cardiac resynchronization therapy: implant rates, temporal trends and relationships with heart failure epidemiology.
Boriani G; Berti E; Belotti LM; Biffi M; Carboni A; Bandini A; Casali E; Tomasi C; Toselli T; Baraldi P; Bottoni N; Barbato G; Sassone B;
J Cardiovasc Med (Hagerstown); 2014 Feb; 15(2):147-54. PubMed ID: 23811841
[TBL] [Abstract][Full Text] [Related]
12. The European Society of Cardiology Cardiac Resynchronization Therapy Survey II: A comparison of cardiac resynchronization therapy implantation practice in Europe and France.
Galand V; Linde C; Lellouche N; Mansourati J; Deharo JC; Sagnol P; Da Costa A; Horvilleur J; Defaye P; Boveda S; Steinbach M; Bru P; Rumeau P; Beard T; Younsi S; Dickstein K; Normand C; Leclercq C
Arch Cardiovasc Dis; 2019 Nov; 112(11):713-722. PubMed ID: 31706879
[TBL] [Abstract][Full Text] [Related]
13. Replacement of implantable cardioverter defibrillators and cardiac resynchronization therapy devices: results of the European Heart Rhythm Association survey.
Tilz R; Boveda S; Deharo JC; Dobreanu D; Haugaa KH; Dagres N
Europace; 2016 Jun; 18(6):945-9. PubMed ID: 27297231
[TBL] [Abstract][Full Text] [Related]
14. Clinical and organizational management of cardiac implantable electronic device replacements: an Italian Survey promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing).
Palmisano P; Ziacchi M; Belotti G; Rapacciuolo A; Santini L; Stabile G; Zoni Berisso M; De Ponti R; Landolina M; Ricci RP; Boriani G;
J Cardiovasc Med (Hagerstown); 2019 Aug; 20(8):531-541. PubMed ID: 31259858
[TBL] [Abstract][Full Text] [Related]
15. Battery drain in daily practice and medium-term projections on longevity of cardioverter-defibrillators: an analysis from a remote monitoring database.
Boriani G; Ritter P; Biffi M; Ziacchi M; Diemberger I; Martignani C; Valzania C; Valsecchi S; Padeletti L; Gadler F
Europace; 2016 Sep; 18(9):1366-73. PubMed ID: 26847076
[TBL] [Abstract][Full Text] [Related]
16. Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1993-2006.
Kurtz SM; Ochoa JA; Lau E; Shkolnikov Y; Pavri BB; Frisch D; Greenspon AJ
Pacing Clin Electrophysiol; 2010 Jun; 33(6):705-11. PubMed ID: 20059714
[TBL] [Abstract][Full Text] [Related]
17. Standards for device implantation and follow-up: personnel, equipment, and facilities: results of the European Heart Rhythm Association Survey.
Todd D; Bongiorni MG; Hernandez-Madrid A; Dagres N; Sciaraffia E; Blomström-Lundqvist C;
Europace; 2014 Aug; 16(8):1236-9. PubMed ID: 25074974
[TBL] [Abstract][Full Text] [Related]
18. Current trends in the use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology member countries: 2015 report from the European Heart Rhythm Association.
Raatikainen MJ; Arnar DO; Zeppenfeld K; Merino JL; Kuck KH; Hindricks G
Europace; 2015 Aug; 17 Suppl 4():iv1-72. PubMed ID: 26286028
[TBL] [Abstract][Full Text] [Related]
19. Multi-Center, Community-Based Cardiac Implantable Electronic Devices Registry: Population, Device Utilization, and Outcomes.
Gupta N; Kiley ML; Anthony F; Young C; Brar S; Kwaku K
J Am Heart Assoc; 2016 Mar; 5(3):e002798. PubMed ID: 26961369
[TBL] [Abstract][Full Text] [Related]
20. Frequency of in-hospital adverse outcomes and cost utilization associated with cardiac resynchronization therapy defibrillator implantation in the United States.
Patel N; Viles-Gonzalez J; Agnihotri K; Arora S; Patel NJ; Aneja E; Shah M; Badheka AO; Pothineni NV; Kancharla K; Mulpuru S; Noseworthy PA; Kusumoto F; Cha YM; Deshmukh AJ
J Cardiovasc Electrophysiol; 2018 Oct; 29(10):1425-1435. PubMed ID: 30016005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
